186 related articles for article (PubMed ID: 11194014)
1. Correlation of serum lipoprotein(a) with the clinical presentation of Thai coronary artery disease patients.
Leowattana W; Mahanonda N; Bhuripanyo K; Pokum S; Worawattananon P
J Med Assoc Thai; 2000 Nov; 83 Suppl 2():S194-8. PubMed ID: 11194014
[TBL] [Abstract][Full Text] [Related]
2. [Endothelin and big endothelin in coronary heart disease and acute coronary syndromes].
Borries M; Heins M; Fischer Y; Stiegler H; Schoebel FC; Reinauer H; Strauer BE; Leschke M
Z Kardiol; 1996 Oct; 85(10):761-7. PubMed ID: 9036701
[TBL] [Abstract][Full Text] [Related]
3. [Changes of plasma von Willebrond factor and soluble E-selectin levels in patients with coronary artery disease].
Lin GQ; Jiang HH; Li YQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):399-402. PubMed ID: 16190382
[TBL] [Abstract][Full Text] [Related]
4. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
5. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T
Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860
[TBL] [Abstract][Full Text] [Related]
6. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
Almagor M; Keren A; Banai S
Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) in cerebrovascular and coronary atherosclerosis.
Nomura S
Hiroshima J Med Sci; 1995 Dec; 44(4):133-9. PubMed ID: 8857237
[TBL] [Abstract][Full Text] [Related]
8. The complex link between oxidised low-density lipoprotein and unstable angina.
Niccoli G; Mongiardo R; Lanza GA; Ricco A; Burzotta F; Trani C; Mazzari MA; Liuzzo G; Lombardo A; Rebuzzi AG; Holvoet P; Crea F
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):387-91. PubMed ID: 17443110
[TBL] [Abstract][Full Text] [Related]
9. Acute versus chronic myocardial ischemia: a differential biological profile study.
Sagastagoitia JD; Sáez Y; Vacas M; Narváez I; de Lafuente JP; Molinero E; Escobar A; Lafita M; Iriarte JA
Pathophysiol Haemost Thromb; 2008; 36(2):91-7. PubMed ID: 19127089
[TBL] [Abstract][Full Text] [Related]
10. [Plasma fibrinogen during the acute stage of angina or myocardial infarct].
de la Llata-Romero M; Cancino C; Cuan V; López-Santibáñez J; Silvia Oropeza E; Ariza-Andraca H
Gac Med Mex; 1997; 133(3):175-80; discussion 181. PubMed ID: 9303865
[TBL] [Abstract][Full Text] [Related]
11. Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis.
Güray U; Erbay AR; Güray Y; Yilmaz MB; Boyaci AA; Sasmaz H; Korkmaz S; Kütük E
Int J Cardiol; 2004 Aug; 96(2):235-40. PubMed ID: 15262039
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein (a) and lipid and non-lipid risk factors in coronaries risk assessment.
Agoşton-Coldea L; Rusu LD; Zdrenghea D; Rusu ML; Pop D; Crăciun A; Poanta L; Gatfossé M; Rosenstingl S; Mocan T
Rom J Intern Med; 2008; 46(2):137-44. PubMed ID: 19284085
[TBL] [Abstract][Full Text] [Related]
13. [Importance of lipoprotein(a) in patients with ischemic heart disease].
Nakamura Y; Yokoi Y; Hamaguchi H; Toyonaga T; Kondo T; Takami S; Kubo M; Matsuzawa Y
J Cardiol; 1992; 22(2-3):319-23. PubMed ID: 1339790
[TBL] [Abstract][Full Text] [Related]
14. [Homocysteine, lipoprotein (a): risk factors for coronary heart disease].
Laraqui A; Bennouar N; Meggouh F; Allami A; El Kadiri N; Benkouka F; Azeddoug H; El Haitem N; Benomar A; Fellat S; Benomar M
Ann Biol Clin (Paris); 2002; 60(5):549-57. PubMed ID: 12368140
[TBL] [Abstract][Full Text] [Related]
15. The role of platelets CD40 ligand (CD154) in acute coronary syndromes.
Abu el-Makrem MA; Mahmoud YZ; Sayed D; Nassef NM; Abd el-Kader SS; Zakhary M; Ghazaly T; Matta R
Thromb Res; 2009 Dec; 124(6):683-8. PubMed ID: 19656553
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction.
Dunder K; Lind L; Lagerqvist B; Zethelius B; Vessby B; Lithell H
Am Heart J; 2004 Mar; 147(3):502-8. PubMed ID: 14999201
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
Cavusoglu Y; Gorenek B; Alpsoy S; Unalir A; Ata N; Timuralp B
Isr Med Assoc J; 2001 Jan; 3(1):13-6. PubMed ID: 11344793
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein (a) in coronary artery disease in Indian population.
Govindaraju V; Neelam ; Manjunath CN; Sundar KK
J Indian Med Assoc; 2003 Aug; 101(8):458-60, 462. PubMed ID: 15071797
[TBL] [Abstract][Full Text] [Related]
19. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
[TBL] [Abstract][Full Text] [Related]
20. Gender differences and in-hospital mortality in patients undergoing percutaneous coronary interventions.
Nowakowska-Arendt A; Grabczewska Z; Koziński M; Sukiennik A; Swiatkiewicz I; Grześk G; Radomski M; Bogdan M; Kochman W; Kubica J
Kardiol Pol; 2008 Jun; 66(6):632-9; discussion 640-1. PubMed ID: 18626832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
